A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty
Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Osteoarthritis; Rheumatoid Arthritis; Arthritis; Traumatic Arthritis
Intervention: Hip Resurfacing System (Device); M2a-Magnum⢠Large Metal Articulation (Device)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Biomet Orthopedics, Inc.
Summary
The primary purpose of this study is to compare early functional outcomes in patients
undergoing hip resurfacing and total hip arthroplasty with the M2a-Magnum™ using more
objective measures of function.
Clinical Details
Official title: Functional Recovery Following Hip Resurfacing or Total Hip Arthroplasty in Patients Matched By Age, Gender, and Activity Level
Study design: Treatment, Non-Randomized, Open Label, Parallel Assignment
Primary outcome: Functional Tests
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients requiring hip arthroplasty
Exclusion Criteria:
- Patients with sensory, neurological, or general health conditions that alter
perception of their limb in space
- Patients with vestibular disorders
Locations and Contacts
Biomet Orthopedics, Inc., Warsaw, Indiana 46581, United States
Additional Information
Starting date: June 2007
Ending date: September 2010
Last updated: December 21, 2007
|
